Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Translation of messenger RNA** (often referred to as *mRNA translation*) is not itself a discrete molecule, gene, or therapeutic target, but rather a fundamental biochemical process by which the genetic code carried by mature messenger RNA (mRNA) is decoded by a ribosome to produce a specific sequence of amino acids, forming a polypeptide or protein[1][2][6][7]. This process requires complex interaction between mRNA, transfer RNA (tRNA), and ribosomal RNA (rRNA) along with ribosomal proteins and numerous translation factors[1][3][6]. Translation is essential for cellular protein synthesis, occurs in all living organisms, and is divided into three main stages: initiation, elongation, and termination[1][6]. While various steps or molecular components of the translation process (such as specific ribosomal subunits or translation factors) may be targeted for therapeutic intervention, the process of "messenger RNA translation" as a whole is not considered a single, actionable therapeutic target[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translation of messenger RNA.